The team behind the technology

Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.

Read More

Prenetics leadership team

Danny Yeung

Group CEO (Co-founder) Prenetics/ CircleDNA

Avi Lasarow

CEO Prenetics EMEA & DNAfit, Hon. Consul South Africa to UK

Andrew Steele

Head of Product Prenetics EMEA & DNAfit

Rio Ferdinand

Subject Expert/ Player Engagement Prenetics EMEA & DNAfit

Brian Stephenson

Head of Operations, Prenetics EMEA & DNAfit

Jotika Behari

Data Information Security, Prenetics EMEA & DNAfit

Dereck Chisora

Subject Expert/ Player Engagement Prenetics EMEA & DNAfit

Prenetics’ expert scientific consortium

Dr. Rachel Liebmann

Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists

Dr. Mark Atkin

Consultant Virologist, The Doctor’s Laboratory

Dr. Senthil Sundaram, MD

Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing

Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT

Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility

Scientific working group

Prof. Alan McNally, BSC, PhD

Director of Institute of Microbiology and Infection, University of Birmingham

Prof. Willem Van Schaik, MSc, PhD

Institute of Microbiology and infection, University of Birmingham

Prof. Michael M Yang, PhD

Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong

Dr. Richard H. Kaszynski, M.A, M.D,PhD

Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan

Company Address: Prenetics EMEA Ltd, Unit 2, Orpington Business Park, Faraday Way, Orpington, Kent BR5 3AA, United Kingdom

Company Registration Number: 08834823

© 2021 Project Screen | Privacy Policy | Terms of Service | All rights reserved